1Life President Niño Namoco, Laboratory Partnerships and Compliance Head Allister Adam Oraña, SGD President Ritche Joseph Manuel Evidente, and COO Norely Gil formalized the partnership through the signing of a memorandum of agreement at SGD's office in Robinsons Cyber Omega, Ortigas, Pasig City.
YAKAP is PhilHealth's flagship preventive healthcare program, focused on early diagnosis and timely intervention to prevent disease progression and hospitalization among all PhilHealth members and their dependents, regardless of age. As an accredited PhilHealth YAKAP provider, 1Life Inc. delivers these preventive benefits, with its partnership with Singapore Diagnostics enabling patients to access required laboratory tests at no expense.
The covered tests include a complete blood count (CBC), lipid profile, fasting blood sugar, oral glucose tolerance test, HbA1C, urinalysis, fecalysis, fecal occult blood test, and creatinine test, which physicians commonly rely on to detect diabetes, kidney disease, and cardiovascular conditions in their early stages.
Available branches span key urban centers across the country. In Metro Manila, locations include Makati, Las Piñas, Marikina, Parañaque, Pasay, San Juan, Diliman in Quezon City, and two Pasig branches at Robinsons Cyber Omega and Strata. In Luzon, the network extends to Angeles City and San Fernando City in Pampanga, Dagupan City and Urdaneta in Pangasinan, Baguio City in Benguet, and Tarlac City. In the Visayas, branches are in the Reclamation Area in Mabolo and Cebu City, Iloilo City and Mandurriao in Iloilo, and Bacolod in Negros Occidental. In Mindanao, patients may access services in Davao City, Davao del Sur, and General Santos City in South Cotabato.
SGD, founded in 2013, has grown to more than 60 locations nationwide and serves over 600 hospitals and clinics, with satellite laboratories in Angeles City, Cebu City, Dagupan City, Davao City, and Iloilo City, giving the partnership immediate logistical depth across the country's major regions.
The deal marks a significant expansion milestone for 1Life, which has served more than one million patients across all 81 provinces and over 1,300 cities and municipalities in just two years of operations. The company uses artificial intelligence-supported clinical workflows to compress what traditionally requires at least four patient visits into a single healthcare encounter.
1Life positions the SGD partnership as central to its preventive care strategy, arguing that access to free diagnostics is a prerequisite for early disease detection, particularly in geographically and economically underserved communities where laboratory services have historically been out of reach.
“Preventive care only works if people can actually get tested, and that has always been 1Life's mission. Partnering with trusted laboratory providers is fundamental to this, because accurate diagnoses and sound treatment decisions begin with reliable diagnostics. When a patient can receive a comprehensive laboratory workup at no cost, that goes beyond diagnosis. That is an opportunity for a healthier life," 1Life President Niño Namoco said.
1Life operates as a social enterprise with an advocacy to strengthen community-level primary healthcare in the country. The company intends to continue growing its laboratory facility network through additional partnerships beyond SGD.
To learn more about free laboratory services under the 1Life, Inc. and SGD partnership, visit 1life.ph and facebook.com/1life.ph. The 1Life Health App is available for download on Google Play and the App Store.
YAKAP is PhilHealth's flagship preventive healthcare program, focused on early diagnosis and timely intervention to prevent disease progression and hospitalization among all PhilHealth members and their dependents, regardless of age. As an accredited PhilHealth YAKAP provider, 1Life Inc. delivers these preventive benefits, with its partnership with Singapore Diagnostics enabling patients to access required laboratory tests at no expense.
The covered tests include a complete blood count (CBC), lipid profile, fasting blood sugar, oral glucose tolerance test, HbA1C, urinalysis, fecalysis, fecal occult blood test, and creatinine test, which physicians commonly rely on to detect diabetes, kidney disease, and cardiovascular conditions in their early stages.
Available branches span key urban centers across the country. In Metro Manila, locations include Makati, Las Piñas, Marikina, Parañaque, Pasay, San Juan, Diliman in Quezon City, and two Pasig branches at Robinsons Cyber Omega and Strata. In Luzon, the network extends to Angeles City and San Fernando City in Pampanga, Dagupan City and Urdaneta in Pangasinan, Baguio City in Benguet, and Tarlac City. In the Visayas, branches are in the Reclamation Area in Mabolo and Cebu City, Iloilo City and Mandurriao in Iloilo, and Bacolod in Negros Occidental. In Mindanao, patients may access services in Davao City, Davao del Sur, and General Santos City in South Cotabato.
SGD, founded in 2013, has grown to more than 60 locations nationwide and serves over 600 hospitals and clinics, with satellite laboratories in Angeles City, Cebu City, Dagupan City, Davao City, and Iloilo City, giving the partnership immediate logistical depth across the country's major regions.
The deal marks a significant expansion milestone for 1Life, which has served more than one million patients across all 81 provinces and over 1,300 cities and municipalities in just two years of operations. The company uses artificial intelligence-supported clinical workflows to compress what traditionally requires at least four patient visits into a single healthcare encounter.
1Life positions the SGD partnership as central to its preventive care strategy, arguing that access to free diagnostics is a prerequisite for early disease detection, particularly in geographically and economically underserved communities where laboratory services have historically been out of reach.
“Preventive care only works if people can actually get tested, and that has always been 1Life's mission. Partnering with trusted laboratory providers is fundamental to this, because accurate diagnoses and sound treatment decisions begin with reliable diagnostics. When a patient can receive a comprehensive laboratory workup at no cost, that goes beyond diagnosis. That is an opportunity for a healthier life," 1Life President Niño Namoco said.
1Life operates as a social enterprise with an advocacy to strengthen community-level primary healthcare in the country. The company intends to continue growing its laboratory facility network through additional partnerships beyond SGD.
To learn more about free laboratory services under the 1Life, Inc. and SGD partnership, visit 1life.ph and facebook.com/1life.ph. The 1Life Health App is available for download on Google Play and the App Store.
.png)
